Good picks!_老虎社区_美港股上老虎

averagesgboy
2021-03-23

Good picks!

Here Are Five Stocks Top Analysts Are Heavily Bullish On, Heading Into April<blockquote>以下是顶级分析师在进入四月份时非常看好的五只股票</blockquote>

Despitein flation fears as the economy reopens after a wider COVID-19 vaccination rollout, there are

Here Are Five Stocks Top Analysts Are Heavily Bullish On, Heading Into April<blockquote>以下是顶级分析师在进入四月份时非常看好的五只股票</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":353933841,"tweetId":"353933841","gmtCreate":1616453108483,"gmtModify":1634525799707,"author":{"id":3569717550531954,"idStr":"3569717550531954","authorId":3569717550531954,"authorIdStr":"3569717550531954","name":"averagesgboy","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Good picks!</body></html>","htmlText":"<html><head></head><body>Good picks!</body></html>","text":"Good picks!","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/353933841","repostId":1141741176,"repostType":4,"repost":{"id":"1141741176","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1616411375,"share":"https://www.laohu8.com/m/news/1141741176?lang=zh_CN&edition=full","pubTime":"2021-03-22 19:09","market":"us","language":"en","title":"Here Are Five Stocks Top Analysts Are Heavily Bullish On, Heading Into April<blockquote>以下是顶级分析师在进入四月份时非常看好的五只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141741176","media":"Benzinga","summary":"Despitein flation fears as the economy reopens after a wider COVID-19 vaccination rollout, there are","content":"Despitein&nbsp;flation fears&nbsp;as the economy reopens after a wider COVID-19 vaccination rollout, there are stocks that analysts are highly bullish on. Here’s a list of best-performing Wall Street analysts’ top five stocks with “Buy” ratings, as&nbsp;compiled&nbsp;by TipRanks.<blockquote>尽管随着更广泛的COVID-19疫苗接种推广后经济重新开放，人们担心通胀，但分析师仍高度看好一些股票。以下是TipRanks编制的表现最佳的华尔街分析师给予“买入”评级的前五只股票列表。</blockquote> Amazon Inc: Baird analyst Colin Sebastian has reiterated a “Buy” rating and has a $4,000 price target in addition to a “Fresh Pick” status on the e-commerce giant. Colin has&nbsp;support from&nbsp;30 other top analysts who have a “Buy” rating as well, as per TipRanks.<blockquote>亚马逊公司：Baird分析师Colin Sebastian重申了“买入”评级，并将这家电子商务巨头的目标价定为4,000美元，此外还给予这家电子商务巨头“新精选”地位。根据TipRanks的数据，科林得到了其他30名顶级分析师的支持，他们也给予了“买入”评级。</blockquote> Sebastian noted that investors could be missing \"one of the most compelling subscription/quasi-subscription models within the Internet and Technology sectors,” adding that&nbsp;75% of Amazon’s revenue is recurring even as it keeps adding new subscribers effectively.<blockquote>塞巴斯蒂安指出，投资者可能会错过“互联网和技术领域最引人注目的订阅/准订阅模式之一”，并补充说，尽管亚马逊不断有效地增加新订阅者，但其75%的收入都是经常性的。</blockquote> Baird sees Amazon as \"significantly undervalued\" and can see it headed to $5,000 per share in the medium-term.<blockquote>贝尔德认为亚马逊“被严重低估”，并预计其在中期内将达到每股5,000美元。</blockquote> With a 75% success rate and 34.8% average return per rating, Sebastian is ranked 28 out of over 7,000 analysts tracked by TipRanks.<blockquote>Sebastian的成功率为75%，每次评级的平均回报率为34.8%，在TipRanks追踪的7,000多名分析师中排名第28位。</blockquote> Microsoft Corp: Wedbush analyst Daniel Ives maintained a “Buy” rating and a $300 price target on the stock as he sees cloud growth momentum building up for the company. The rest of the Wall Street analysts are bullish as well with a total of 23 “Buy” ratings on the stock.<blockquote>微软公司：Wedbush分析师Daniel Ives维持该股“买入”评级和300美元的目标价，因为他认为该公司的云增长势头正在增强。其余华尔街分析师也持看涨态度，共有23名分析师对该股给予“买入”评级。</blockquote> Ives estimates that cloud wars between Amazon and Microsoft to capture market share are going to intensify and global cloud spending could reach nearly $1 trillion over the next decade.<blockquote>Ives估计，亚马逊和微软之间争夺市场份额的云战争将会加剧，未来十年全球云支出可能会达到近1万亿美元。</blockquote> The veteran analyst has&nbsp;predicted a shift in tide&nbsp;in the cloud space, with Microsoft standing to benefit.<blockquote>这位资深分析师预测云领域的潮流将发生转变，微软将从中受益。</blockquote> Alphatec Holdings: Medical technology company focused on spinal surgeries has six “Buy” ratings from top analysts and a $19.7 average stock price forecast.&nbsp;H.C. Wainwright analyst Sean Lee, who claims a 75% success rate and 69.2% average return per rating, has maintained a “Buy” rating on the stock and raised the price target to $19 from $16.<blockquote>阿尔法泰克控股：专注于脊柱手术的医疗科技公司获得顶级分析师的六次“买入”评级，平均股价预测为19.7美元。Wainwright分析师Sean Lee声称每次评级的成功率为75%，平均回报率为69.2%，他维持该股的“买入”评级，并将目标价从16美元上调至19美元。</blockquote> Lee’s rating comes after the company’s fourth-quarter revenue registered a 36% year-over-year surge despite the ongoing COVID-19 headwinds. The analyst expects EOS imaging to be a key growth driver for the company, contributing about $127 million in additional revenues by 2025.<blockquote>尽管COVID-19持续存在不利因素，但该公司第四季度收入仍同比增长36%，Lee做出了这一评级。该分析师预计EOS imaging将成为该公司的关键增长动力，到2025年将贡献约1.27亿美元的额外收入。</blockquote> Alphatec's recently-launched procedure for lateral surgeries that significantly shortens the surgery times could also be a major growth driver this year.<blockquote>Alphatec最近推出的横向手术程序可显着缩短手术时间，也可能成为今年的主要增长动力。</blockquote> Addus Homecare Corp: Brokerage RBC Capital analyst Frank Morgan, who has a 5-star rating on the stock, has reiterated a \"Buy\" rating and a price target of $136.<blockquote>Addus家庭护理公司：券商RBC Capital分析师Frank Morgan对该股给予5星评级，重申“买入”评级，目标价为136美元。</blockquote> The Texas-based home and healthcare company recently unveiled a new value plan to support closer coordination of care for patients as they are discharged from acute care hospitals into their homes or into post-acute facilities.<blockquote>这家总部位于德克萨斯州的家庭和医疗保健公司最近公布了一项新的价值计划，以支持在患者从急症护理医院出院到家中或急症后设施时更密切地协调护理。</blockquote> Morgan believes the plan “positions Addus for a larger role in post-acute coordination with potential for longer-term shared savings.” The analyst is also encouraged by the recently passed COVID federal relief aid as “it provides a 10% boost to the Federal Medical Assistance Percentage meant to bolster personal care services amid the pandemic.”<blockquote>摩根认为，该计划“使Addus在急性后协调中发挥更大的作用，并有可能实现长期共享储蓄。”这位分析师还对最近通过的新冠联邦救济援助感到鼓舞，因为“它将联邦医疗援助百分比提高了10%，旨在加强大流行期间的个人护理服务。”</blockquote> This increase gives a larger match than Morgan originally expected, with earlier versions of the bill mentioning a 7.35% rise.<blockquote>这一涨幅比摩根最初预期的要大，该法案的早期版本提到了7.35%的涨幅。</blockquote> Amyris Inc: H.C. Wainwright analyst Amit Dayal is bullish on the stock and has significantly roasted its price target to $35 from $11 and reiterated the “Buy” rating as well.<blockquote>阿米里斯公司：H.C.Wainwright分析师Amit Dayal看好该股，并将其目标价从11美元大幅上调至35美元，并重申了“买入”评级。</blockquote> Dayal, who has a 77% average per rating, along with three top analysts, has a similar view on the stock in the last two months. The average analyst price target comes in at $25.50.<blockquote>Dayal的平均评级为77%，他和三位顶级分析师在过去两个月对该股也有类似的看法。分析师平均目标价为25.50美元。</blockquote> Dayal sees improving business fundamentals that support the company’s annual revenue growth outlook expectations of between 30% and 50% over the next few years. Also, its debt is set to land below $100 million by the end of the third quarter this year from $297 million at the beginning of 2020.<blockquote>Dayal认为，业务基本面的改善支持该公司未来几年年收入增长预期在30%至50%之间。此外，到今年第三季度末，其债务将从2020年初的2.97亿美元降至1亿美元以下。</blockquote> The brokerage says the company currently has 18 ingredients currently in development that could position the company to have more than 30 commercialized ingredients by the end of 2025. In addition, it has four new brand launches in 2021, is expanding its retail presence, and could benefit from acquisitions and distribution agreements in international markets including China and Brazil.<blockquote>该券商表示，该公司目前有18种成分正在开发中，到2025年底，该公司可能会拥有30多种商业化成分。此外，该公司在2021年推出了四个新品牌，正在扩大其零售业务，并可能受益于中国和巴西等国际市场的收购和分销协议。</blockquote> Based on all of the above, the analyst argues that revenues will grow at a nine-year CAGR from 2021 to 2030 of 28.8%, versus the previous 20.4% estimate.<blockquote>基于上述所有情况，分析师认为，从2021年到2030年，收入将以28.8%的九年复合年增长率增长，而之前的预测为20.4%。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here Are Five Stocks Top Analysts Are Heavily Bullish On, Heading Into April<blockquote>以下是顶级分析师在进入四月份时非常看好的五只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere Are Five Stocks Top Analysts Are Heavily Bullish On, Heading Into April<blockquote>以下是顶级分析师在进入四月份时非常看好的五只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nBenzinga \n2021-03-22 19:09\n</div>\n</div>\n</h4>\n</header>\n<article>\nDespitein&nbsp;flation fears&nbsp;as the economy reopens after a wider COVID-19 vaccination rollout, there are stocks that analysts are highly bullish on. Here’s a list of best-performing Wall Street analysts’ top five stocks with “Buy” ratings, as&nbsp;compiled&nbsp;by TipRanks.<blockquote>尽管随着更广泛的COVID-19疫苗接种推广后经济重新开放，人们担心通胀，但分析师仍高度看好一些股票。以下是TipRanks编制的表现最佳的华尔街分析师给予“买入”评级的前五只股票列表。</blockquote> Amazon Inc: Baird analyst Colin Sebastian has reiterated a “Buy” rating and has a $4,000 price target in addition to a “Fresh Pick” status on the e-commerce giant. Colin has&nbsp;support from&nbsp;30 other top analysts who have a “Buy” rating as well, as per TipRanks.<blockquote>亚马逊公司：Baird分析师Colin Sebastian重申了“买入”评级，并将这家电子商务巨头的目标价定为4,000美元，此外还给予这家电子商务巨头“新精选”地位。根据TipRanks的数据，科林得到了其他30名顶级分析师的支持，他们也给予了“买入”评级。</blockquote> Sebastian noted that investors could be missing \"one of the most compelling subscription/quasi-subscription models within the Internet and Technology sectors,” adding that&nbsp;75% of Amazon’s revenue is recurring even as it keeps adding new subscribers effectively.<blockquote>塞巴斯蒂安指出，投资者可能会错过“互联网和技术领域最引人注目的订阅/准订阅模式之一”，并补充说，尽管亚马逊不断有效地增加新订阅者，但其75%的收入都是经常性的。</blockquote> Baird sees Amazon as \"significantly undervalued\" and can see it headed to $5,000 per share in the medium-term.<blockquote>贝尔德认为亚马逊“被严重低估”，并预计其在中期内将达到每股5,000美元。</blockquote> With a 75% success rate and 34.8% average return per rating, Sebastian is ranked 28 out of over 7,000 analysts tracked by TipRanks.<blockquote>Sebastian的成功率为75%，每次评级的平均回报率为34.8%，在TipRanks追踪的7,000多名分析师中排名第28位。</blockquote> Microsoft Corp: Wedbush analyst Daniel Ives maintained a “Buy” rating and a $300 price target on the stock as he sees cloud growth momentum building up for the company. The rest of the Wall Street analysts are bullish as well with a total of 23 “Buy” ratings on the stock.<blockquote>微软公司：Wedbush分析师Daniel Ives维持该股“买入”评级和300美元的目标价，因为他认为该公司的云增长势头正在增强。其余华尔街分析师也持看涨态度，共有23名分析师对该股给予“买入”评级。</blockquote> Ives estimates that cloud wars between Amazon and Microsoft to capture market share are going to intensify and global cloud spending could reach nearly $1 trillion over the next decade.<blockquote>Ives估计，亚马逊和微软之间争夺市场份额的云战争将会加剧，未来十年全球云支出可能会达到近1万亿美元。</blockquote> The veteran analyst has&nbsp;predicted a shift in tide&nbsp;in the cloud space, with Microsoft standing to benefit.<blockquote>这位资深分析师预测云领域的潮流将发生转变，微软将从中受益。</blockquote> Alphatec Holdings: Medical technology company focused on spinal surgeries has six “Buy” ratings from top analysts and a $19.7 average stock price forecast.&nbsp;H.C. Wainwright analyst Sean Lee, who claims a 75% success rate and 69.2% average return per rating, has maintained a “Buy” rating on the stock and raised the price target to $19 from $16.<blockquote>阿尔法泰克控股：专注于脊柱手术的医疗科技公司获得顶级分析师的六次“买入”评级，平均股价预测为19.7美元。Wainwright分析师Sean Lee声称每次评级的成功率为75%，平均回报率为69.2%，他维持该股的“买入”评级，并将目标价从16美元上调至19美元。</blockquote> Lee’s rating comes after the company’s fourth-quarter revenue registered a 36% year-over-year surge despite the ongoing COVID-19 headwinds. The analyst expects EOS imaging to be a key growth driver for the company, contributing about $127 million in additional revenues by 2025.<blockquote>尽管COVID-19持续存在不利因素，但该公司第四季度收入仍同比增长36%，Lee做出了这一评级。该分析师预计EOS imaging将成为该公司的关键增长动力，到2025年将贡献约1.27亿美元的额外收入。</blockquote> Alphatec's recently-launched procedure for lateral surgeries that significantly shortens the surgery times could also be a major growth driver this year.<blockquote>Alphatec最近推出的横向手术程序可显着缩短手术时间，也可能成为今年的主要增长动力。</blockquote> Addus Homecare Corp: Brokerage RBC Capital analyst Frank Morgan, who has a 5-star rating on the stock, has reiterated a \"Buy\" rating and a price target of $136.<blockquote>Addus家庭护理公司：券商RBC Capital分析师Frank Morgan对该股给予5星评级，重申“买入”评级，目标价为136美元。</blockquote> The Texas-based home and healthcare company recently unveiled a new value plan to support closer coordination of care for patients as they are discharged from acute care hospitals into their homes or into post-acute facilities.<blockquote>这家总部位于德克萨斯州的家庭和医疗保健公司最近公布了一项新的价值计划，以支持在患者从急症护理医院出院到家中或急症后设施时更密切地协调护理。</blockquote> Morgan believes the plan “positions Addus for a larger role in post-acute coordination with potential for longer-term shared savings.” The analyst is also encouraged by the recently passed COVID federal relief aid as “it provides a 10% boost to the Federal Medical Assistance Percentage meant to bolster personal care services amid the pandemic.”<blockquote>摩根认为，该计划“使Addus在急性后协调中发挥更大的作用，并有可能实现长期共享储蓄。”这位分析师还对最近通过的新冠联邦救济援助感到鼓舞，因为“它将联邦医疗援助百分比提高了10%，旨在加强大流行期间的个人护理服务。”</blockquote> This increase gives a larger match than Morgan originally expected, with earlier versions of the bill mentioning a 7.35% rise.<blockquote>这一涨幅比摩根最初预期的要大，该法案的早期版本提到了7.35%的涨幅。</blockquote> Amyris Inc: H.C. Wainwright analyst Amit Dayal is bullish on the stock and has significantly roasted its price target to $35 from $11 and reiterated the “Buy” rating as well.<blockquote>阿米里斯公司：H.C.Wainwright分析师Amit Dayal看好该股，并将其目标价从11美元大幅上调至35美元，并重申了“买入”评级。</blockquote> Dayal, who has a 77% average per rating, along with three top analysts, has a similar view on the stock in the last two months. The average analyst price target comes in at $25.50.<blockquote>Dayal的平均评级为77%，他和三位顶级分析师在过去两个月对该股也有类似的看法。分析师平均目标价为25.50美元。</blockquote> Dayal sees improving business fundamentals that support the company’s annual revenue growth outlook expectations of between 30% and 50% over the next few years. Also, its debt is set to land below $100 million by the end of the third quarter this year from $297 million at the beginning of 2020.<blockquote>Dayal认为，业务基本面的改善支持该公司未来几年年收入增长预期在30%至50%之间。此外，到今年第三季度末，其债务将从2020年初的2.97亿美元降至1亿美元以下。</blockquote> The brokerage says the company currently has 18 ingredients currently in development that could position the company to have more than 30 commercialized ingredients by the end of 2025. In addition, it has four new brand launches in 2021, is expanding its retail presence, and could benefit from acquisitions and distribution agreements in international markets including China and Brazil.<blockquote>该券商表示，该公司目前有18种成分正在开发中，到2025年底，该公司可能会拥有30多种商业化成分。此外，该公司在2021年推出了四个新品牌，正在扩大其零售业务，并可能受益于中国和巴西等国际市场的收购和分销协议。</blockquote> Based on all of the above, the analyst argues that revenues will grow at a nine-year CAGR from 2021 to 2030 of 28.8%, versus the previous 20.4% estimate.<blockquote>基于上述所有情况，分析师认为，从2021年到2030年，收入将以28.8%的九年复合年增长率增长，而之前的预测为20.4%。</blockquote>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMRS":"阿米瑞斯","MSFT":"微软","AMZN":"亚马逊","ATEC":"阿尔法泰克","ADUS":"爱德斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141741176","content_text":"Despitein flation fears as the economy reopens after a wider COVID-19 vaccination rollout, there are stocks that analysts are highly bullish on. Here’s a list of best-performing Wall Street analysts’ top five stocks with “Buy” ratings, as compiled by TipRanks.\nAmazon Inc: Baird analyst Colin Sebastian has reiterated a “Buy” rating and has a $4,000 price target in addition to a “Fresh Pick” status on the e-commerce giant. Colin has support from 30 other top analysts who have a “Buy” rating as well, as per TipRanks.\nSebastian noted that investors could be missing \"one of the most compelling subscription/quasi-subscription models within the Internet and Technology sectors,” adding that 75% of Amazon’s revenue is recurring even as it keeps adding new subscribers effectively.\nBaird sees Amazon as \"significantly undervalued\" and can see it headed to $5,000 per share in the medium-term.\nWith a 75% success rate and 34.8% average return per rating, Sebastian is ranked 28 out of over 7,000 analysts tracked by TipRanks.\nMicrosoft Corp: Wedbush analyst Daniel Ives maintained a “Buy” rating and a $300 price target on the stock as he sees cloud growth momentum building up for the company. The rest of the Wall Street analysts are bullish as well with a total of 23 “Buy” ratings on the stock.\nIves estimates that cloud wars between Amazon and Microsoft to capture market share are going to intensify and global cloud spending could reach nearly $1 trillion over the next decade.\nThe veteran analyst has predicted a shift in tide in the cloud space, with Microsoft standing to benefit.\nAlphatec Holdings: Medical technology company focused on spinal surgeries has six “Buy” ratings from top analysts and a $19.7 average stock price forecast. H.C. Wainwright analyst Sean Lee, who claims a 75% success rate and 69.2% average return per rating, has maintained a “Buy” rating on the stock and raised the price target to $19 from $16.\nLee’s rating comes after the company’s fourth-quarter revenue registered a 36% year-over-year surge despite the ongoing COVID-19 headwinds. The analyst expects EOS imaging to be a key growth driver for the company, contributing about $127 million in additional revenues by 2025.\nAlphatec's recently-launched procedure for lateral surgeries that significantly shortens the surgery times could also be a major growth driver this year.\nAddus Homecare Corp: Brokerage RBC Capital analyst Frank Morgan, who has a 5-star rating on the stock, has reiterated a \"Buy\" rating and a price target of $136.\nThe Texas-based home and healthcare company recently unveiled a new value plan to support closer coordination of care for patients as they are discharged from acute care hospitals into their homes or into post-acute facilities.\nMorgan believes the plan “positions Addus for a larger role in post-acute coordination with potential for longer-term shared savings.” The analyst is also encouraged by the recently passed COVID federal relief aid as “it provides a 10% boost to the Federal Medical Assistance Percentage meant to bolster personal care services amid the pandemic.”\nThis increase gives a larger match than Morgan originally expected, with earlier versions of the bill mentioning a 7.35% rise.\nAmyris Inc: H.C. Wainwright analyst Amit Dayal is bullish on the stock and has significantly roasted its price target to $35 from $11 and reiterated the “Buy” rating as well.\nDayal, who has a 77% average per rating, along with three top analysts, has a similar view on the stock in the last two months. The average analyst price target comes in at $25.50.\nDayal sees improving business fundamentals that support the company’s annual revenue growth outlook expectations of between 30% and 50% over the next few years. Also, its debt is set to land below $100 million by the end of the third quarter this year from $297 million at the beginning of 2020.\nThe brokerage says the company currently has 18 ingredients currently in development that could position the company to have more than 30 commercialized ingredients by the end of 2025. In addition, it has four new brand launches in 2021, is expanding its retail presence, and could benefit from acquisitions and distribution agreements in international markets including China and Brazil.\nBased on all of the above, the analyst argues that revenues will grow at a nine-year CAGR from 2021 to 2030 of 28.8%, versus the previous 20.4% estimate.","news_type":1,"symbols_score_info":{"MSFT":0.9,"AMRS":0.9,"ADUS":0.9,"ATEC":0.9,"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":1062,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}